COVID-19 & CancerFreeGuest Editorial ASCO data will provide actionable insights from the COVID-19 pandemic—for every patient June 05, 2020Vol.46 No.23By Richard L. Schilsky
FreeGuest Editorial Fostering a culture of gender-based respect and inclusion in oncology June 05, 2020Vol.46 No.23By Narjust Florez, Christina Chapman, Stephanie L. Graff, Tatiana M. Prowell and Miriam A. Knoll
FreeGuest Editorial I could have been George Floyd—many timesReflecting on the cancer of racism June 05, 2020Vol.46 No.23By Robert A. Winn
COVID-19 & CancerFreeGuest Editorial CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19 May 29, 2020Vol.46 No.22By Otis W. Brawley
COVID-19 & CancerFreeGuest Editorial CCC19 bridging the knowledge gap for patients with COVID-19 and cancerFirst results to be heard at 2020 ASCO Annual Meeting May 22, 2020Vol.46 No.21By Rana R. McKay, Toni K. Choueiri, Brian I. Rini and Jeremy L. Warner
COVID-19 & CancerFreeGuest Editorial Let’s not form blue ribbon panels to study disparities in COVID-19 deathsInstead, let’s find the will to act May 22, 2020Vol.46 No.21By Robert A. Winn and Katherine Y. Tossas
COVID-19 & CancerFreeGuest Editorial SARS-CoV-2 and oncology drugsWhat do we mean when we talk about value? May 15, 2020Vol.46 No.20By Garth W. Strohbehn, Daniel A. Goldstein and Mark J. Ratain
COVID-19 & CancerFreeGuest Editorial With the COVID-19 pandemic, the cancer clinical trials—they are a-changing May 08, 2020Vol.46 No.19By Gregory Masters, Nicholas J. Petrelli and Kandie Dempsey
COVID-19 & CancerFreeGuest Editorial Embracing the increasing value of eHealth in patient-centered cancer care during the COVID-19 pandemic and beyond May 08, 2020Vol.46 No.19By Frank J. Penedo and Joshua Kronenfeld
